Dental Bone Graft Substitutes Market

Executive Summary

Dental Bone Graft Substitutes Market was valued at US $707.97 million in 2021 and is projected to grow at 9.73% CAGR over the forecast period to reach US $1,235.72 million by 2027. Dental Bone Graft Substitutes Market represented US $119.97 million opportunity over 2019-2021 and estimated to create US $527.76 million opportunity in 2027 over 2021.

Dental Bone Graft Substitutes from Consainsights analyses the Dental Bone Graft Substitutes Market in the Life Sciences industry over the forecast period to 2027.

Dental Bone Graft Substitutes research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Dental Bone Graft Substitutes segmentation includes Type, Application, Product and Geography.

Based on the Type, the Dental Bone Graft Substitutes analysis covers Synthetic Bone Graft, Xenograft, Allograft, Demineralized Allograft.

In Type segment, Synthetic Bone Graft segment has highest cagr growth of 8.60%.

Based on the Application, the Dental Bone Graft Substitutes analysis covers Socket Preservation, Ridge Augmentation, Periodontal Defect Regeneration, Implant Bone Regeneration, Sinus Lift.

In Application segment, Socket Preservation segment has highest cagr growth of 8.60%.

Based on the Product, the Dental Bone Graft Substitutes analysis covers Bio Oss, Osteograf, Grafton.

In Product segment, Bio Oss segment has highest cagr growth of 8.60%.

Based on the region, the Dental Bone Graft Substitutes analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Dentsply Sirona International, Biohorizons Iph, Inc., Geistlich Pharma Ag, Medtronic, Institut Straumann Ag, Zimmer Holding Inc, Lifenet Health, Rti Surgical, Inc., Dentium and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Type

Introduction

In 2021, Synthetic Bone Graft segment has the highest revenue of US $361.14 million and is expected to grow at CAGR of 8.60% by 2027 Synthetic Bone Graft segment has highest cagr growth of 8.60%.

Synthetic Bone Graft

Synthetic Bone Graft segment was valued at US $299.94 million in 2019 and is projected to grow at 8.60% CAGR over the forecast period to reach US $630.35 million by 2027. Synthetic Bone Graft segment represented US $61.20 million opportunity over 2019-2021 and estimated to create US $269.21 million opportunity in 2027 over 2021.

Xenograft

Xenograft segment was valued at US $171.62 million in 2019 and is projected to grow at 8.60% CAGR over the forecast period to reach US $360.67 million by 2027. Xenograft segment represented US $35.02 million opportunity over 2019-2021 and estimated to create US $154.04 million opportunity in 2027 over 2021.

Allograft

Allograft segment was valued at US $107.46 million in 2019 and is projected to grow at 8.60% CAGR over the forecast period to reach US $225.84 million by 2027. Allograft segment represented US $21.92 million opportunity over 2019-2021 and estimated to create US $96.45 million opportunity in 2027 over 2021.

Demineralized Allograft

Demineralized Allograft segment was valued at US $8.98 million in 2019 and is projected to grow at 8.60% CAGR over the forecast period to reach US $18.86 million by 2027. Demineralized Allograft segment represented US $1.83 million opportunity over 2019-2021 and estimated to create US $8.06 million opportunity in 2027 over 2021.

Application

Introduction

In 2021, Socket Preservation segment has the highest revenue of US $314.42 million and is expected to grow at CAGR of 8.60% by 2027 Socket Preservation segment has highest cagr growth of 8.60%.

Socket Preservation

Socket Preservation segment was valued at US $261.14 million in 2019 and is projected to grow at 8.60% CAGR over the forecast period to reach US $548.81 million by 2027. Socket Preservation segment represented US $53.28 million opportunity over 2019-2021 and estimated to create US $234.39 million opportunity in 2027 over 2021.

Ridge Augmentation

Ridge Augmentation segment was valued at US $146.13 million in 2019 and is projected to grow at 8.60% CAGR over the forecast period to reach US $307.11 million by 2027. Ridge Augmentation segment represented US $29.82 million opportunity over 2019-2021 and estimated to create US $131.16 million opportunity in 2027 over 2021.

Periodontal Defect Regeneration

Periodontal Defect Regeneration segment was valued at US $111.74 million in 2019 and is projected to grow at 8.60% CAGR over the forecast period to reach US $234.82 million by 2027. Periodontal Defect Regeneration segment represented US $22.80 million opportunity over 2019-2021 and estimated to create US $100.29 million opportunity in 2027 over 2021.

Implant Bone Regeneration

Implant Bone Regeneration segment was valued at US $45.49 million in 2019 and is projected to grow at 8.60% CAGR over the forecast period to reach US $95.60 million by 2027. Implant Bone Regeneration segment represented US $9.28 million opportunity over 2019-2021 and estimated to create US $40.83 million opportunity in 2027 over 2021.

Sinus Lift

Sinus Lift segment was valued at US $23.50 million in 2019 and is projected to grow at 8.60% CAGR over the forecast period to reach US $49.38 million by 2027. Sinus Lift segment represented US $4.79 million opportunity over 2019-2021 and estimated to create US $21.09 million opportunity in 2027 over 2021.

Product

Introduction

In 2021, Bio Oss segment has the highest revenue of US $408.18 million and is expected to grow at CAGR of 8.60% by 2027 Bio Oss segment has highest cagr growth of 8.60%.

Bio Oss

Bio Oss segment was valued at US $339.01 million in 2019 and is projected to grow at 8.60% CAGR over the forecast period to reach US $712.46 million by 2027. Bio Oss segment represented US $69.17 million opportunity over 2019-2021 and estimated to create US $304.28 million opportunity in 2027 over 2021.

Osteograf

Osteograf segment was valued at US $137.58 million in 2019 and is projected to grow at 8.60% CAGR over the forecast period to reach US $289.13 million by 2027. Osteograf segment represented US $28.07 million opportunity over 2019-2021 and estimated to create US $123.48 million opportunity in 2027 over 2021.

Grafton

Grafton segment was valued at US $111.41 million in 2019 and is projected to grow at 8.60% CAGR over the forecast period to reach US $234.14 million by 2027. Grafton segment represented US $22.73 million opportunity over 2019-2021 and estimated to create US $100.00 million opportunity in 2027 over 2021.